The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ labels warning ...

The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation ...

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say SSRIs are a crucial treatment option for women with perinatal depression.